Welcome!

Marketwired .

Subscribe to Marketwired .: eMailAlertsEmail Alerts
Get Marketwired . via: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


News Feed Item

ProPhotonix Announces Application for Block Admission

SALEM, NH -- (Marketwired) -- 12/05/17 -- ProPhotonix Limited (OTC: STKR) (AIM: PPIX)

OTC: STKR and AIM: PPIX

ProPhotonix Announces Application for Block Admission

(Salem, New Hampshire, December 5, 2017) ProPhotonix Limited (OTC: STKR and London Stock Exchange - AIM: PPIX), announces that an application for block admission has been made for 19,497,867 common shares of US$0.001 each ("Common Shares") in the Company ("Block Admission Shares") which will be issued from time to time in accordance with the rules of the Company's 2007 and 2014 Stock Incentive Plans, pursuant to share options granted between 2009 and 2017.

The Block Admission Shares will rank pari passu in all respects with the existing issued Common Shares of the Company and it is expected that admission will become effective on 7 December 2017.

The Company will provide notifications when there are changes to the issued share capital, in order for shareholders to calculate whether they are required to notify their interest in, or a change to their interest in, the share capital of the Company.

Contact:

ProPhotonix Limited                   Tel: +1 603 893 8778

Tim Losik, President & CEO            ir@prophotonix.com

Cantor Fitzgerald Europe              Tel: +44 (0)207 894 7000
(Nominated Adviser and Broker)

Andrew Craig

Richard Salmond

About ProPhotonix

ProPhotonix Limited, headquartered in Salem, New Hampshire, is a high technology designer and manufacturer of LED illumination systems and laser diode modules for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Ushio (formerly OCLARO), Osram, QSI, Panasonic, and Sony. The Company serves a wide range of markets including the machine vision, industrial inspection, security, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's website at www.prophotonix.com.

This information is provided by RNS
The company news service from the London Stock Exchange

END

Contact:
RNS
Customer Services
0044-207797-4400
rns@londonstockexchange.com
http://www.rns.com

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.